Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrawound Vancomycin for Neural Stimulator
NCT03221023Phase 3Unknown
- Sponsor
- University of British Columbia
- Start
- Sep 2017
- Primary completion
- Sep 2021
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of vancomycin in surgical site infection (SSI) (2 arms), sponsored by University of British Columbia. Primary endpoint: Device explantation due to infection at 6 months. Status: unknown.
02
Drugs
vancomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03221023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03221023.